AKT1 and cancer: The considerable number of these genes, exactly 55, were enriched (p-value < 0.05) in critical pathways in cancer such as PI3K-Akt signaling pathway (4.69 fold enrichment, p-value 2.04e−08), proteoglycans in cancer (6.07 fold, p-value 1.03e−07), FoxO signaling pathway (6.64 fold, p-value 4.55e−06).